3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
2
Active not recruiting
1
Sponsor Class
OTHER
1
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Colorectal Neoplasms
1
Interventions
Specimen Handling
18
Cyclophosphamide
17
Magnetic Resonance Spectroscopy
16
Dexamethasone
15
Cisplatin
14
Vincristine
13
Radiotherapy
13
Radiation
11
Etoposide
10
Carboplatin
10
durvalumab
9
Radiotherapy, Intensity-Modulated
9
Paclitaxel
9
Doxorubicin
8
Cytarabine
8
Temozolomide
7
Rituximab
7
Prednisone
7
Lenalidomide
7
Irinotecan
7
Gemcitabine
7
Fluorouracil
7
Docetaxel
7
Bortezomib
7
Biopsy
7
daratumumab
6
Platinum
6
Leucovorin
6
Capecitabine
6
tremelimumab
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
NETWORK
×
Sulindac
×
Clear all
NCT01349881
2026-04-02
PACES
SWOG Cancer Research Network
Phase 3
Active not recruiting
354 enrolled